Hodgkin’s Disease is a cancer that has a very high survival rate. However, there are still those who are not lucky enough to be one of the over 85% who are cured after initial chemotherapy and radiation treatments.
The Kimberly D. Holland Hodgkin’s Disease Foundation is a not-for-profit 501(c)3 which was established in 1999 by Kimberly and Randi Holland. Kimberly was diagnosed in March 1994 with Stage IIB Hodgkin’s Disease and is still currently undergoing treatments for the disease 19 years later.
The Foundation was organized to fund clinical trials, research and publications relating to finding a cure for Hodgkin’s Disease. Out of the 10 clinical trials that Kim was on since 2001, the FDA approved the very first clinical trial drug called SGN-35 in august of 2011…the first to be approved for Hodgkin Lymphoma since 1977.
Donations to this foundation will be forwarded to the research and clinical trial Department at Memorial Sloan-Kettering Cancer Center in New York City, New York , led by Dr. Andrew Zelenetz M.D. , Chief of Oncology.
The goal of this website is to provide information on one individual’s experiences, not a medical expert’s advice. We have consulted many sources to compile this information, and as such, it should be used only for informational purposes. Please seek professional medical help for more information. Visit Memorial Sloan-Kettering Cancer Center or for more information about this website or to contact us, please email email@example.com.